Grossman William Insider Trades & Stock Holdings

Interim Chief Medical Officer · enGene Therapeutics Inc. · Latest filing Sep 22, 2026

Grossman William, Interim Chief Medical Officer at enGene Therapeutics Inc. has 1 Form 4 trade on file since Sep 22, 2026. Open-market activity: 1 purchase ($10.05K) and 0 sales ($0), net +$10.05K. Latest filing: acquired 5.10K shares of $ENGN on Sep 22, 2026 at $1.97.

Trades on file

1

Open-market bought

$10.05K

Open-market sold

$0

Net open-market

+$10.05K

Latest filing

Sep 22, 2026

All insider trades by Grossman William

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 22, 2026	$ENGN	Buy (Open-market buy)	5.10K	$1.97	$10.05K			-4.9%			Interim Chief Medical Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Grossman William traded

• $ENGN

Frequently asked questions

Has Grossman William been buying or selling stock?

Grossman William has 1 open-market purchase and 0 open-market sales on file, net +$10.05K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Grossman William's latest insider trade?

acquired 5.10K shares of $ENGN on Sep 22, 2026 at $1.97.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.